AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 20.295 USD -2.19% Market Closed
Market Cap: 612.5m USD
Have any thoughts about
AnaptysBio Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-1.8
Current
-2.2
Median
6
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-1.8
=
Enterprise Value
187.4m USD
/
Operating Cash Flow
-103m USD
All Countries
Close
 
US
AnaptysBio Inc
NASDAQ:ANAB
Average EV/OCF: 23.1
Negative Multiple: -1.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 051.4
US
Abbvie Inc
NYSE:ABBV
21.4
US
Amgen Inc
NASDAQ:AMGN
28.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -127
US
Gilead Sciences Inc
NASDAQ:GILD
11
US
E
Epizyme Inc
F:EPE
Negative Multiple: -477
AU
CSL Ltd
ASX:CSL
35.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
US
S
Seagen Inc
F:SGT
Negative Multiple: -74.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126.8

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More